Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
This piece outlines What To Buy After Tax Loss Harvest Dividend ETF, including replacement candidates and criteria to choose wisely.
23,181 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Two popular EM ETFs face off: schwab emerging markets ishares and EEM. This guide breaks down costs, performance, and...
SpaceX stock appears to be trading well below its IPO price, but price alone doesn’t determine value. Here’s a practi...
A tech sell-off can feel overwhelming, but it often creates value for patient buyers. This guide shows how to identif...
Goldman Sachs issued four high-conviction calls across four stocks, pairing two Buy upgrades with two Sell downgrades...
When mood is grim, many wonder if it’s time to abandon stocks. History says the market often bounces back; smart, dis...
Crypto markets may be thawing after a years-long winter. This deep-dive explains the signals behind the claim and off...
AI data centers are expanding fast, backed by major cloud players. This article dives into why hyperscalers plan spen...
When a spouse dies, a widow must act within 12 months to claim a survivor benefit on the late partner’s Social Securi...
Palantir stock has fallen from its all-time high, but a fall doesn’t mean a free pass to buy. This guide breaks down ...
Berkshire Hathaway ramps up buybacks and sits on a large cash cushion, while Pershing Square slips 16% year-to-date a...
European leaders weigh price caps on essentials to curb inflation, a move that has CEOs warning of market distortions...